Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside

Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside

BackgroundImmune checkpoint inhibitor (ICI) therapy is first-line treatment for many advanced non-small cell lung cancer (aNSCLC) patients. Predicting response could help guide selection of intensified or alternative anti-cancer regimens. We hypothesized that radiomics and laboratory variables predi...

Full description

Bibliographic Details
Main Authors: Chris Montoya, Benjamin Spieler, Scott M. Welford, Deukwoo Kwon, Alan Dal Pra, Gilberto Lopes, Ivaylo B. Mihaylov
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
lung cancer
immunotherapy
radiotherapy
systemic response
local response
radiomics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1225720/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1225720/full

Similar Items